secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stimcell Energetics Inc. (STME)
CIK:        0001493712
Form:       8-K
Filed at:   2023-12-19T23:59:59+00:00
Accession:  0001393905-23-000412
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.02, 5.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cell MedX settles $1.62M debt with 231.8M shares at $0.007; new CEO David Jeffs appointed
--------------------------------------------------------------------------------

- Dwayne Yaretz resigns as CEO, Brad Hargreaves resigns as VP of Tech & Ops; both remain directors.
- David Jeffs appointed new CEO; Jeffs and Amir Vahabzadeh appointed to the board.
- Debt of $1,622,693 settled with 231,813,310 shares at $0.007/share.
- Post-settlement, Jeffs and family hold ~40%; Vahabzadeh and spouse hold ~29% of shares.
- Completion of debt settlement will result in a change in control of Cell MedX.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1493712/000139390523000412/0001393905-23-000412-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1493712/000139390523000412/cmxc-20231212.htm
  HTML page:      https://secwatch.observer/filing/0001393905-23-000412

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer